USP51 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.98823204964083E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.61630000003765E-07 |
Normal-vs-Stage2 |
1.73140000003791E-06 |
Normal-vs-Stage3 |
8.32667268468867E-15 |
Normal-vs-Stage4 |
3.21964677141295E-15 |
Stage1-vs-Stage2 |
9.993800E-02 |
Stage1-vs-Stage3 |
1.57557000000086E-05 |
Stage1-vs-Stage4 |
2.67279999999204E-06 |
Stage2-vs-Stage3 |
1.899400E-01 |
Stage2-vs-Stage4 |
4.363800E-02 |
Stage3-vs-Stage4 |
2.371000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.11095593730215E-12 |
Normal-vs-AfricanAmerican |
1.67930000016803E-07 |
Normal-vs-Asian |
1.810230E-02 |
Caucasian-vs-AfricanAmerican |
3.655600E-01 |
Caucasian-vs-Asian |
8.310000E-01 |
AfricanAmerican-vs-Asian |
5.975600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.65401026208656E-12 |
Normal-vs-Female |
6.40049999667269E-08 |
Male-vs-Female |
5.618400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.359160E-03 |
Normal-vs-Age(41-60Yrs) |
4.68630001471126E-09 |
Normal-vs-Age(61-80Yrs) |
3.23074900165921E-14 |
Normal-vs-Age(81-100Yrs) |
3.84880000003918E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.228200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.379400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.503000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.646100E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.964400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.747400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.176400E-01 |
Normal-vs-Grade 2 |
1.27029999963391E-07 |
Normal-vs-Grade 3 |
5.10902431472005E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
2.488800E-01 |
Grade 1-vs-Grade 3 |
5.067700E-02 |
Grade 1-vs-Grade 4 |
1.66460000006197E-07 |
Grade 2-vs-Grade 3 |
1.482310E-02 |
Grade 2-vs-Grade 4 |
8.71747118935673E-13 |
Grade 3-vs-Grade 4 |
1.01320000001071E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.37469999999829E-05 |
Normal-vs-ccB subtype |
8.23452417364479E-13 |
ccA subtype-vs-ccB subtype |
1.429460E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.21431770089475E-12 |
Normal-vs-N1 |
1.06989972437077E-10 |
N0-vs-N1 |
1.033540E-02 |
|
|